What is Transmed?
Established in 1986 and headquartered in Sioux Falls, Transmed has evolved into a cornerstone of regional healthcare infrastructure. The company specializes in a comprehensive suite of ultrasound services, ranging from complex cardiac and vascular assessments to routine obstetrics and stroke screenings. With a workforce comprised of ARDMS-registered sonographers and a track record of Joint Commission accreditation since 2014, Transmed maintains a rigorous focus on patient safety and clinical precision. Its business model effectively bridges the gap between specialized diagnostic needs and accessibility, providing mobile, high-fidelity imaging services directly to healthcare providers and patients alike.
How much funding has Transmed raised?
Transmed has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Transmed
PPP
Public-Private Partnership
What's next for Transmed?
With this late-stage capital infusion, Transmed is well-positioned to accelerate its operational scaling and technological integration. The company is expected to prioritize the modernization of its mobile fleet and the expansion of its diagnostic capabilities to meet the rising demand for decentralized healthcare services. By maintaining its stringent quality standards while scaling its geographic reach, Transmed aims to further entrench its role as an essential partner in the diagnostic imaging ecosystem. Future growth will likely focus on enhancing service delivery efficiency and exploring advanced imaging modalities to maintain its competitive edge in the evolving medical technology landscape.
See full Transmed company page
